(±) 20-HDHA

(±) 20-HDHA ((±) 20-HDoHE) is a racemic mixture and is an autoxidation product of Docosahexaenoic acid (DHA) . (±) 20-HDHA is also formed by peroxidation process in human platelets and rat brain homogenate[1][2][3].

Product Specifications

CAS Number

[90906-41-5]

Product Name Alternative

(±) 20-HDoHE

UNSPSC

12352211

Hazard Statement

H302, H315, H319, H335

Target

Endogenous Metabolite

Type

Natural Products

Related Pathways

Metabolic Enzyme/Protease

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/racemic-20-hdha.html

Concentration

290.28 μM * 750 μL in Ethanol

Purity

97.0

Solubility

10 mM in DMSO

Smiles

CCC(O)/C=C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(O)=O

Molecular Formula

C22H32O3

Molecular Weight

344.49

Precautions

H302, H315, H319, H335

References & Citations

[1]VanRollins M, et al. Autooxidation of docosahexaenoic acid: analysis of ten isomers of hydroxydocosahexaenoate. J Lipid Res. 1984 May;25 (5) :507-17.|[2]Kim HY, et al. Stereochemical analysis of hydroxylated docosahexaenoates produced by human platelets and rat brain homogenate. Prostaglandins. 1990 Nov;40 (5) :473-90.|[3]Hong S, et al. Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: Analysis via electrospray/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms. J Am Soc Mass Spectrom. 2007 Jan;18 (1) :128-44.